Global Coalition for the Elimination of Congenital Syphilis

One shot.
Many partners.

Every year, syphilis in pregnancy causes more than 390,000 stillbirths, newborn deaths, premature births and lifelong disabilities. A test that costs 84 cents finds it. A penicillin injection under 50 cents stops it. Almost none of it should still be happening.

Twenty-six organizations — governments, UN agencies, funders, researchers and implementers — have come together to end congenital syphilis in at least ten high-burden countries within the decade.

A preventable tragedy, at scale

A pregnant woman makes her way to antenatal care. She is screened and counselled for HIV, but not syphilis. Months later she delivers a stillborn baby and no one ever tells her why.

This happens hundreds of thousands of times a year.
390,000+

Adverse pregnancy outcomes each year — about 150,000 stillbirths, 70,000 newborn deaths, and 170,000 premature births and severe disabilities

~700,000

Congenital syphilis cases globally in 2022

+11%

Increase in a baby’s likelihood of exposure compared with eight years ago

~6%

Share of adverse outcomes occurring in mothers who were fully screened and treated — the rest is a delivery failure, not a medical one

New HIV infections in children under five

2010
310,000
2024
120,000

The contrast with HIV tells the story.

New HIV infections in children under five fell 62% between 2010 and 2024 — the result of sustained global attention and money. Over the same period, congenital syphilis has gone the other way.

The same women, in the same clinics, on the same day.

The whole intervention costs under $1.50

Step 01

One finger prick

A dual rapid test screens for HIV and syphilis at once — about four cents more than the HIV-only test many countries already buy. Results come back in minutes.

$0.84
Step 02

Same visit, same day

If she is positive, she is treated immediately with benzathine penicillin.

<$0.50
Step 03

Most harm averted

Treatment before the third trimester prevents 82% of stillbirths, 80% of newborn deaths and 97% of congenital syphilis cases.

97%
No new clinic network. No adherence regimen. No behaviour-change campaign. Over 80% of pregnant women in high-burden countries already attend antenatal care and are already tested for HIV. What is missing is the dual test in the room, a health worker trained to use it, and penicillin on the shelf.

Nobody does this alone

The coalition starts somewhere else: with the scale of the problem, and the question of who needs to be at the table.

The division of labor is already clear from the countries where this works:

Global Fund
and other multilateral and bilateral partners fund the tests
Governments
fund and sustain the treatment
Government health workers
deliver the care
Implementing organizations
provide technical assistance where each is strongest

Thirty organizations. One goal.

Membership is open to UN agencies, donors, implementing partners, research institutions, community organizations and country representatives committed to congenital syphilis elimination — and to organizations working across the broader triple elimination agenda and comprehensive maternal care.

Membership is open. If your organization works on congenital syphilis, triple elimination or comprehensive maternal care, there is a place for you.

Inquire about joining

The window is this year

Countries are writing their Global Fund proposals for the 2027–2029 cycle right now. What a country leaves out of that budget, it does without until 2030.

At the same time, the landscape is contracting.

  • PEPFAR is being restructured following the closure of USAID, and its priorities are narrowing
  • Global Fund replenishment is likely to fall short
  • Congenital syphilis rates are rising

Tighter resources make prioritization more important, not less. Scarce dollars should move toward interventions where the evidence is strong, the economics are compelling, and the route to durable government ownership is real. There are not many that clear all three. This is one.

Tools for the GC8 application

Policy endorsement alone does not put syphilis in a funding request. The application asks for commodity quantities, cost documentation and narrative justification that many country teams have not had to prepare for syphilis before. Coalition members have built the tools to close that gap.

Evidence Action · Global Fund GC8, 2027–2029

GC8 Syphilis Toolkit

Resources for country teams, technical assistance partners and Country Coordinating Mechanisms integrating dual HIV/syphilis rapid tests and benzathine penicillin G into GC8 funding proposals.

  • Syphilis integration checklist — the full GC8 application timeline, from country dialogue to pre-submission review, with syphilis-specific actions at each stage.
  • Quantification and budget calculator — an Excel tool generating three-year procurement quantities, landed cost budgets and funding scenarios for dual tests and BPG.
  • Impact evidence package — proposal-ready narrative language, cost-effectiveness evidence and citations formatted for GC8 applications.
  • One-page evidence brief — for CCM meetings, Ministry of Health discussions and stakeholder planning sessions.

Companion resources from partners

GC8 Integration Toolkit

Practical guidance for integrating hepatitis, harm reduction and triple elimination into HIV programs.

View toolkit

EVT Integration Toolkit for GC8

A three-part toolkit for positioning elimination of vertical transmission within GC8 applications.

View toolkit

Integration Primer & RAPID Tool

Pragmatic guidance for advancing integrated systems and services across primary health care.

View primer

There is a place in this coalition

Whether you fund, implement, research or set policy, there is a place in this coalition. Members meet quarterly by video, share what they are learning, and help shape the investment case and advocacy agenda the field needs.

We’ll send coalition updates, webinar invitations and notice of moments like the World Health Assembly, IAS and AlignMNH. Unsubscribe any time.